GlassScriptPhysician profile
Jared L Szymanski
NPI 1952343402
$1,785.38
in general payments reported to CMS, 2019-2025
4 companies · $520 in 2025
The $520 reported for 2025 was more than what 86% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,111 · 2023: $154 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $520 · Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $520.00 |
| Food and Beverage | $153.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $1,222.64 | 2021-2023 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $520.00 | 2025 | Truqap |
| Cepheid | $23.38 | 2023 | Genexpert |
| Siemens Medical Solutions USA, INC. | $19.36 | 2023 | Atellica Im 1300 Analyzer, Atellica Ch 930 Analyzer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Szymanski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.